Caprolactam Chemicals Ltd Stock Price Today (NSE: CAPRO)

Caprolactam Chemicals Ltd

49.000.80 (1.61%)
Market Closed

Fundamental Score

...

Caprolactam Chemicals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Caprolactam Chemicals Ltd share price today is 49.00, down 1.61% on NSE/BSE as of 7 August 2026. Caprolactam Chemicals Ltd (CAPRO) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 21.85 (Cr). The 52-week high for CAPRO share price is 81.00 and the 52-week low is 38.10. At a P/E ratio of 12.42x, CAPRO is currently trading below its industry average P/E of 22.30x. The company has a Return on Equity (ROE) of 30.85% and a debt-to-equity ratio of 1.40.

Caprolactam Chemicals Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
51.50
Low
43.37
Volume
109.36363636363636
Change
+7.11%

Caprolactam Chemicals Ltd share price chart: 7.11% return over the past month. 52-week high ₹81.00, 52-week low ₹38.10.

Caprolactam Chemicals Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
49.0049.0049.0049.00200.00 (Cr)
49.9949.9949.8049.801.01K (Cr)
49.3649.4849.3649.484.00 (Cr)
49.5049.5049.5049.500.00 (Cr)
49.4549.5049.4549.50337.00 (Cr)
44.0047.9043.3747.8841.00 (Cr)
45.6545.6545.6545.65100.00 (Cr)
48.0048.0048.0048.001.00 (Cr)
48.0048.0048.0048.00368.00 (Cr)
48.0048.0048.0048.0011.00 (Cr)

Caprolactam Chemicals Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
49.4549.9949.0049.00-0.91%
44.7051.5043.3747.88+7.11%
49.0451.4943.3444.70-8.85%
44.3155.5344.3049.04+10.67%
45.0558.4538.1046.57+3.37%
68.9868.9845.0545.05-34.69%
69.7272.8065.7172.61+4.15%
52.0881.0047.5173.38+40.90%
63.2669.0052.0852.08-17.67%
47.2060.2544.2560.25+27.65%
45.0046.9440.5045.15+0.33%
48.2549.9743.6044.09-8.62%

AI Research Briefing

Powered by Gemini · 2026-04-08

Micro-cap commodity chemicals play with weak financials and a history of struggles; current price momentum is unsustainable.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEBreakout. 1M: 40.11%, 3M: 37.1%, 6M: 48.88%Expensive. P/E ratio of 2910.48x significantly higher than the industry P/E of 20.98x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Caprolactam Chemicals Ltd. (CAPRO) saw its shareholders unanimously approve resolutions related to executive pay and related party transactions via postal ballot on March 30, 2026. The trading window closed on April 1, 2026, in anticipation of the Q4 FY26 results.

CORE STORY (THE REAL GAME)

CAPRO is a micro-cap commodity chemical company, highly susceptible to raw material price fluctuations and broader industry cycles. The market appears to be pricing in a turnaround based on recent YoY profit growth, but the company's history and current financials suggest caution.

Why Now
  • Recent positive price momentum (1M: 40.11%, 3M: 37.1%)
  • Latest quarter YoY profit increased by 225.0%
  • Unanimous shareholder approval on key resolutions
Potential Catalysts
  • Significant debt reduction
  • Consistent profitability over multiple quarters
  • Major order wins with clear ₹ value
Key Risks
  • Micro/SME cap: Illiquidity risk
  • Negative ROE and ROCE
  • High P/E ratio of 2910.48x vs. industry P/E of 20.98x
  • High debt/equity ratio of 1.7 and low-interest coverage of 1.19x
  • Negative free cash flow over the past 5 years
Institutional Activity

No FII or DII holdings. Promoter holding is stable.

Macro Context

The Indian chemicals industry is projected to grow, but faces challenges such as dependence on imported raw materials and stringent environmental regulations.

Order Book / Expansion

No major news found after live search.

Cash Flow Quality

No. Free cash flow 5Y: ₹-4.3 Cr

3–6 Month Outlook

Short-term price momentum may continue, but long-term sustainability is questionable given weak fundamentals. Monitor Q4 results closely for any signs of improvement.

Primary Thesis Risk

Inability to sustain profitability and manage debt will lead to collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

30.85%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

19.69%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

33.90%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Caprolactam Chemicals Ltd Valuation Check

Excellent

Price to Earnings (P/E)

12.42x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

22.30x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

54.50%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

286.67%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

90.68%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.85%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

22.04%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

22.04%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.40x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.01x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-4.84 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Caprolactam Chemicals Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CAPRO across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (30.85%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (19.69%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (33.90%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 12.42 vs Industry: 22.30)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (286.67%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (90.68%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Excellent EPS Growth (22.04% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (22.04% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Balanced Promoter Holding (54.50%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Elevated Debt Levels (D/E: 1.40)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Negative Free Cash Flow (₹-4.84 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Caprolactam Chemicals Ltd vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare Caprolactam Chemicals Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
65.6/100
49
₹21.85
12.4
Average
30.85%
Excellent
19.69%
Good
1.4
Average
22.04%
Excellent
10.85%
Good
0.00%
SRF Ltd...
SRF503806
49.2/100
2623
₹82229.24
43.2
Average
14.27%
Average
14.61%
Average
0.4
Excellent
9.70%
Good
13.45%
Good
0.32%
34.6/100
1553
₹19552.98
26.5
Average
11.27%
Average
11.58%
Average
0.8
Good
13.22%
Good
14.65%
Good
0.65%
16.3/100
674
₹17796.24
65.7
Average
1.27%
Poor
3.42%
Poor
0.4
Excellent
2.85%
Average
7.41%
Good
1.58%
56.5/100
510
₹7322.77
9.1
Average
9.13%
Poor
12.03%
Average
0.0
Excellent
3.00%
Average
8.67%
Good
3.61%
56/100
3066
₹5234.46
74.6
Average
20.47%
Excellent
23.66%
Excellent
0.3
Excellent
32.34%
Excellent
36.90%
Excellent
0.18%
32.9/100
671
₹4366.01
-0.04%
Poor
1.40%
Poor
0.1
Excellent
12.40%
Good
2.66%
Ghcl Ltd...
GHCL500171
38.9/100
438
₹4015.23
8.8
Average
12.97%
Average
17.41%
Good
0.0
Excellent
6.60%
Good
4.23%
Average
2.75%
67.5/100
77
₹3609.71
22.0
Average
16.23%
Good
21.35%
Excellent
0.0
Excellent
19.92%
Excellent
14.48%
Good
0.63%
18.4/100
194
₹3088.38
-6.80%
Poor
0.34%
Poor
1.1
Average
2.14%
Average
0.00%
0/100
174
₹2007.48
-11.80%
Poor
-3.15%
Poor
1.4
Average
9.84%
Good
0.00%

Caprolactam Chemicals Ltd PE Ratio History

Historical price-to-earnings ratio for CAPRO — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.43₹55.25128.5x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Caprolactam Chemicals Ltd Quarterly Performance

Latest quarterly metrics for CAPRO — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

90.68%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

286.67%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.85%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

22.04%

Compounded annual net profit growth over 5 years

Caprolactam Chemicals Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for CAPRO — calculated from daily price history

36RSI 14
Neutral — RSI 36

Momentum is balanced — neither overbought nor oversold.

SMA 50
48
▲ Price above SMA 50 — Short-term bullish
SMA 200
51
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
0K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Caprolactam Chemicals Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Caprolactam Chemicals Ltd (CAPRO) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Caprolactam Chemicals Ltd

About CAPRO (Caprolactam Chemicals Ltd)

Caprolactam Chemicals Ltd is a dynamic manufacturer and distributor entrenched within the Indian commodity chemical sector. Established in 1988 and headquartered in Mahad, India, C...APRO distinguishes itself through its focused production and distribution of specialized chemical compounds. The company’s core strength lies in its ability to deliver consistent quality and reliability to its customers, building lasting partnerships across diverse industrial applications. Operating with a lean and efficient organizational structure, CAPRO prioritizes responsiveness to market demands and agility in adapting its production processes. The company is driven by innovation and customer satisfaction, positioning itself as a preferred partner for businesses seeking reliable chemical solutions in India. CAPRO’s operations are not confined solely to manufacturing its own chemical products. A significant aspect of its business model includes providing specialized job work services, leveraging its production expertise and infrastructure to meet the bespoke requirements of other chemical companies. This service offering reflects CAPRO's commitment to optimizing resource utilization and expanding its reach within the chemical industry value chain. By offering comprehensive job work solutions, the company reinforces its position as a versatile and trusted partner, facilitating collaboration and efficiency across the sector. This diversification demonstrates CAPRO's ability to adapt and capitalize on opportunities beyond its primary product offerings. The company's journey began under a different identity, formerly known as Vamotiwala Chemicals Industries Limited, before rebranding to Caprolactam Chemicals Limited. This evolution underscores CAPRO’s strategic vision and its dedication to aligning its corporate identity with its core business focus. The name change reflects a pivotal moment in the company's history, signifying a shift toward specialized chemical production and a renewed commitment to excellence. The company continues to build upon its legacy, enhancing its capabilities to meet the evolving demands of the chemical market while maintaining its steadfast commitment to quality and customer satisfaction.

Company Details

Symbol:CAPRO
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Ms. Zaver Shankarlal Bhanushali
Chairperson & MD
Mr. Siddharth Shankarlal Bhanushali
Whole-time Director & CFO
Ms. Dolly Dipesh Shah
Company Secretary & Compliance Officer

CAPRO Share Price: Frequently Asked Questions

What is the current share price of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd (CAPRO) trades at ₹49.00 on NSE and BSE. Market cap ₹21.85 (Cr). Educational data only.

What is the P/E ratio of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has a P/E of 12.42x vs industry average 22.30x.

What is the Bull Run score for Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has a Bull Run score of 65.6/100 based on 25+ financial parameters.

Does Caprolactam Chemicals Ltd pay dividends?

Caprolactam Chemicals Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has ROE of 30.85%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has debt-to-equity of 1.40.

Is Caprolactam Chemicals Ltd a good investment?

Bull Run gives Caprolactam Chemicals Ltd a score of 65.6/100. This is not investment advice — consult a SEBI-registered advisor.